India Readies More Regulatory Reform, Globally ‘Aligned’ Biosimilars Guidance

US FDA official shares updates on voluntary QMM assessment program

 
• By Anju Ghangurde
  
India is pushing ahead with more regulatory streamlining (Shutterstock)

More from Pathways & Standards

More from Pink Sheet